Clinical Trials Data Supply Chain 
Cannabis Law Report
DECEMBER 27, 2019
A Windsor, Ontario-based company Audacia Bioscience is especially focussed on three patented technologies that deliver consumer and patient insights to the industry to close the knowledge gaps in the supply chain. Virtual Clinical Trials transcend geographic, mobility and economic barriers.
Veriheal
AUGUST 31, 2020
Data shows that Hispanic Americans are more interested in using cannabis and CBD for wellness than other groups and “is believed to be in part due to the connections between the Hispanic community and nature.” Supply chains are disrupted as a result, and consumers grow fearful of buying hemp. Leonardo “Leo” Orozco.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
SEPTEMBER 14, 2021
Comprehensive health-related outcome data from study participants, that is inclusive of highly diverse demographics and behavioral habits, further enables brands to deliver targeted formulations to specific customer segments. Step five: The OBX and Radicle Science validated product is sent to production. Headquartered in Roxboro, N.C.,
Cannabis Law Report
SEPTEMBER 2, 2021
The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S.
Cannabis Law Report
AUGUST 3, 2021
The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S.
Cannabis Law Report
JUNE 7, 2021
1.526 were reduced as expected and consistent with other CDC-reported data on vaccine-induced antibody neutralization against these variants 1. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Dr. James A. Food and Drug Administration (U.S.
Cannabis Law Report
JANUARY 10, 2022
In addition, rising strategic initiatives by key players in the form of collaborations, clinical trials, and production are further contributing to increasing awareness and adoption of THCV products. Rising clinical trials is thus anticipated to boost the adoption and penetration of rare cannabis derivatives in the forthcoming years.
Expert insights. Personalized for you.
85 
Let's personalize your content